JAMA Oncology

Oncology & Cancer

Financial disclosure lacking in publication of clinical trials

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...

Oncology & Cancer

Time to stop cancer screenings: what do patients want to hear?

(HealthDay)—Older adults prefer explanations about stopping cancer screening that emphasize the shift to focus on other health issues, according to a research letter published in the August issue of JAMA Oncology.

Oncology & Cancer

Treatment for severe heartburn prevents cancer

Medical or surgical treatment of severe heartburn prevents cancer of the oesophagus, a study from Karolinska Institutet with almost one million Nordic patients reveals. The results are published in the scientific journal ...

Oncology & Cancer

Scientists identify genetic marker for gastric cancer prognosis

Although immunotherapy is seen as a very promising treatment for cancer, currently only 20 to 30 percent of patients respond positively. Being able to identify the people most likely to benefit from the costly therapy is ...

Oncology & Cancer

Elevated late mortality persists after blood or marrow transplant

(HealthDay)—Individuals who underwent allogeneic blood or marrow transplantation (BMT) in childhood have elevated risk of late mortality 25 years or more after transplantation, according to a study published online July ...

Oncology & Cancer

TGFB1 mutation ups radiation-induced breast fibrosis risk

(HealthDay)—The C-509T allele in the promoter region of transforming growth factor β (TGFB1) is associated with radiation-induced breast fibrosis risk among patients with early-stage breast cancer, according to study published ...

page 34 from 40